Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review-Reference-Cited by-同舟云学术

Efficacy and safety of canakinumab in the treatment of adult-onset Still's disease: A systematic review

Published:2021-12 Issue:6 Volume:51 Page:1282-1290
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Cota-Arce Julián M.,Cota Jonhatan,De León-Nava Marco A.,Hernández-Cáceres Alexia,Moncayo-Salazar Leopoldo I.,Valle-Alvarado Fidel,Cordero-Moreno Vera L.,Bonfil-Solis Karen L.,Bichara-Figueroa Jesús E.,Hernández-Hernández José,Villela Luis

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference75 articles.

1. Presentation and diagnosis of adult-onset Still's disease: the implications of current and emerging markers in overcoming the diagnostic challenge;Colafrancesco;Expert Rev Clin Immunol,2015

2. Adult-onset Still's disease;Gerfaud-Valentin;Autoimmun Rev,2014

3. Characteristics of circulating natural killer cells and their interferon-γ production in active adult-onset Still disease;Shimojima;J Rheumatol,2019

4. Diagnosis and classification of adult Still's disease;Mahroum;J Autoimmun,2014

5. Cysteine-rich angiogenic inducer 61 serves as a potential serum biomarker for the remission of adult-onset still's disease;Su;Front Med,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sore Throat to Still’s: Group A Streptococcus Causing Adult-Onset Still’s Disease;Cureus;2024-09-11

2. Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options;Drugs;2024-03

3. Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs;The Journal of Rheumatology;2024-02-01

4. A Case of Adult-Onset Still’s Disease With Hypocomplementemia;Cureus;2024-01-20

5. Autoantibody-Mediated Depletion of IL-1RA in Still’s Disease and Potential Impact of IL-1 Targeting Therapies;Journal of Clinical Immunology;2024-01-17